IPI Trademark

Trademark Overview

On Tuesday, March 27, 2018, a trademark application was filed for IPI with the United States Patent and Trademark Office. The USPTO has given the IPI trademark a serial number of 87851282. The federal status of this trademark filing is REGISTERED as of Tuesday, April 12, 2022. This trademark is owned by Institute for Protein Innovation, Inc.. The IPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antibodies and antibody fragments for use in the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceuticals, namely, antibodies and antibody fragments for the treatment of fibrotic and inflammatory disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use as antiviral, anti-bacterial, or anti-fungal agents
ipi

General Information

Serial Number87851282
Word MarkIPI
Filing DateTuesday, March 27, 2018
Status700 - REGISTERED
Status DateTuesday, April 12, 2022
Registration Number6701739
Registration DateTuesday, April 12, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Description of MarkThe mark consists of the letters "IPI" with two stylized letter "I"s. The first stylized "I" is a downward facing arrow and the second stylized "I" is an upward facing arrow. The non-arrow end of each stylized "I" is connected to the letter "P" using a thin curved line, where the top of the first stylized letter "I" is connected to the top of the "P" and the base of the second stylized letter "I" is connected to the base of the letter "P".
Goods and ServicesPharmaceuticals, namely, antibodies and antibody fragments for use in the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceuticals, namely, antibodies and antibody fragments for the treatment of fibrotic and inflammatory disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceuticals, namely, antibodies and antibody fragments for use as antiviral, anti-bacterial, or anti-fungal agents
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 3, 2018
Primary Code005
First Use Anywhere DateTuesday, October 27, 2020
First Use In Commerce DateTuesday, October 27, 2020

Trademark Owner History

Party NameInstitute for Protein Innovation, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02115
Party NameInstitute for Protein Innovation, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02115
Party NameInstitute for Protein Innovation, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02115

Trademark Events

Event DateEvent Description
Tuesday, April 12, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 23, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 18, 2021USE AMENDMENT FILED
Wednesday, August 18, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 16, 2021EXTENSION 5 GRANTED
Thursday, July 8, 2021EXTENSION 5 FILED
Friday, July 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 13, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 8, 2021TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021EXTENSION 4 GRANTED
Friday, January 8, 2021EXTENSION 4 FILED
Friday, January 8, 2021TEAS EXTENSION RECEIVED
Friday, July 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 8, 2020EXTENSION 3 GRANTED
Wednesday, July 8, 2020EXTENSION 3 FILED
Wednesday, July 8, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020EXTENSION 2 GRANTED
Monday, January 6, 2020EXTENSION 2 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2019EXTENSION 1 GRANTED
Friday, June 21, 2019EXTENSION 1 FILED
Friday, June 21, 2019TEAS EXTENSION RECEIVED
Friday, March 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 11, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 28, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 17, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2018NON-FINAL ACTION WRITTEN
Thursday, July 12, 2018ASSIGNED TO EXAMINER
Tuesday, April 17, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, April 12, 2018ASSIGNED TO LIE
Wednesday, April 4, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 4, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 2, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 30, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

system pharmaceuticals namely fragments antibody antibodies disorders anti treatment tissue